Revenue ($USD): $18,341,000,000
R&D spend: $1,026,000,000.00
Employees: 50,000
Fiscal year end: 12/31/22
CEO: Peter Arduini
The Chicago-based medtech giant’s second quarter was strong enough that itupped its full-year guidance to 6-8% revenue growth. Imaging, patient care solutions and pharmaceutical diagnostics served as significant growth drivers in Q2.
GE HealthCare has been has been on a tear when it comes to forging partnerships to boost its business. In June, it announced thatit would work with Johnson & Johnson’s DePuy Synthes in the spine space, pairing its OEC 3D Imaging System with the J&J unit’s extensive product portfolio. In March, GE HealthCareannounced a long-term joint venture with Sinopharmas it seeks to make additional inroads in China’s medical device market. It’s alsoinked a 10-year medical device maintenance deal with Advantus Health Partnersworth $760 million.
Other top news this year included theacquisition of Caption Healthand its AI-powered image guidance tech. The FDA alsocleared its Carescape Canvas patient monitoring platform.–CN